Ujwala Salvi

Dr. Ujwala Salvi is a Founder & Chief Executive Officer, at NUCLEON Therapeutics LLP which is a Mumbai based CRO leading in Clinical trial operation, CDM and end to end Pharmacovigilance. Their esteemed client involves MNC Indian Pharma companies and Tier II pharma companies from U.S.

Dr. Salvi has worked in large global operations, managed strategic relationships, and played a key role in winning new business, setting up off-shored partnerships and in identifying new BU service lines and growing existing ones. Her areas of expertise include Pharmacovigilance, Clinical Trial operations, Clinical Data Management and feasibilities of new drug development and Analytics.

She is an MBA in Finance from Indian Institute of Management (IIM), Kolkata & Doctorate in Applied Biology from Mumbai University.